Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer
Denise S. O’Keefe(Cleveland Clinic), Warren D.W. Heston(Cleveland Clinic), Peter L. Molloy(CSIRO Health and Biosecurity), Yoshiaki Uchida(Ibaraki Prefectural Police), Fujiko B. Watt(Commonwealth Scientific and Industrial Research Organisation), Dean J. Bacich(Cleveland Clinic), Annamaria Martorana(University of Palermo)
Cited by 71
Related Papers
De novo identification of differentially methylated regions in the human genome
|Epigenetics & Chromatin|2015|1k
Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter.
|Genes & Development|1988|598
1,2,3‐Triazole in Heterocyclic Compounds, Endowed with Biological Activity, through 1,3‐Dipolar Cycloadditions
|European Journal of Organic Chemistry|2014|341
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
|Journal of Medicinal Chemistry|2022|139
Synthesis and antitumor properties of 2,5-bis(3′-indolyl)thiophenes: Analogues of marine alkaloid nortopsentin
|Bioorganic & Medicinal Chemistry Letters|2007|105